264 related articles for article (PubMed ID: 1502183)
1. Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183
[TBL] [Abstract][Full Text] [Related]
2. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
3. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
[TBL] [Abstract][Full Text] [Related]
4. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
Riggs NL; Little SJ; Richman DD; Guatelli JC
Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
[TBL] [Abstract][Full Text] [Related]
5. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
6. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
Arya SK; Gallo RC
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4486-91. PubMed ID: 8633095
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
Bevec D; Dobrovnik M; Hauber J; Böhnlein E
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
[TBL] [Abstract][Full Text] [Related]
10. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication.
Ahmad N; Maitra RK; Venkatesan S
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6111-5. PubMed ID: 2788283
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses.
Inoue M; Hoxie JA; Reddy MV; Srinivasan A; Reddy EP
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2278-82. PubMed ID: 2006168
[TBL] [Abstract][Full Text] [Related]
12. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.
Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E
Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299
[TBL] [Abstract][Full Text] [Related]
14. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
von Schwedler U; Song J; Aiken C; Trono D
J Virol; 1993 Aug; 67(8):4945-55. PubMed ID: 8331734
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.
Neuveut C; Jeang KT
J Virol; 1996 Aug; 70(8):5572-81. PubMed ID: 8764071
[TBL] [Abstract][Full Text] [Related]
17. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
18. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
Zolotukhin AS; Valentin A; Pavlakis GN; Felber BK
J Virol; 1994 Dec; 68(12):7944-52. PubMed ID: 7966585
[TBL] [Abstract][Full Text] [Related]
19. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
[TBL] [Abstract][Full Text] [Related]
20. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
